X

$XPH

2 articles found
0 positive
0 negative
2 neutral
BenzingaBenzinga··Nabaparna Bhattacharya

Amneal Pharmaceuticals Surges on $1.1B Kashiv Acquisition to Dominate Biosimilars

Amneal Pharmaceuticals surged 3.76% after agreeing to acquire Kashiv BioSciences for $1.1 billion, positioning itself in the $300 billion biosimilars market.
AMRXXPHASCEacquisitionstrategic partnership
BenzingaBenzinga··Nabaparna Bhattacharya

Prestige Consumer Bets $1B on Breathe Right in Bold Sleep Health Push

Prestige Consumer Healthcare agrees to acquire Breathe Right nasal strip brand for $1.045 billion, targeting sleep and respiratory health categories with expected margin expansion and free cash flow benefits by H1 2027.
PBHSAEFXPHacquisitionM&A